David Loew
Chief Executive Officer presso IPSEN
Patrimonio netto: 59 562 $ in data 31/03/2024
Posizioni attive di David Loew
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IPSEN | Director/Board Member | 01/07/2020 | - |
| Chief Executive Officer | 01/07/2020 | - | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Chairman | 30/07/2020 | - |
| European Federation of Pharmaceutical Industries & Assoc | Director/Board Member | - | - |
| G5 Santé | Director/Board Member | - | - |
Storia della carriera di David Loew
Precedenti posizioni note di David Loew
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SANOFI | Corporate Officer/Principal | 01/07/2013 | 15/06/2020 |
| GAVI Alliance | Director/Board Member | - | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/07/2013 | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Formazione di David Loew
| University of St. Gallen | Masters Business Admin |
Statistiche
Distribuzione geografica
| Francia | 5 |
| Svizzera | 4 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 6 |
| Miscellaneous | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| SANOFI | Health Technology |
| IPSEN | Health Technology |
| Aziende private | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| GAVI Alliance | Miscellaneous |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| European Federation of Pharmaceutical Industries & Assoc | |
| G5 Santé |
- Borsa valori
- Insiders
- David Loew
- Esperienza
